Sugi Predict

Sugi Predict / Compounds / SCHEMBL2952691

SCHEMBL2952691

SCHEMBL2952691

O=C(NC1CC1)N1CCNCC1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.57
▸ CHRNB2 P17787 1/20 0.50
▸ CHRNA3 P32297 1/20 0.50
▸ CHRNA4 P43681 1/20 0.50
▸ CHRNB3 Q05901 1/20 0.50
▸ CHRNA6 Q15825 1/20 0.50
▸ POLB P06746 5/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ EPHX1 P07099 2/20 0.48
▸ EPHX2 P34913 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ CHRM5 P08912 1/20 0.46
▸ CHRM3 P20309 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.46
▸ MAPK1 P28482 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ PKM P14618 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28848375 0.98 HTT (0.55) HTTCHRNB2CHRNA3CHRNA4CHRNB3
Hydrochloric Acid SCHEMBL29943384 0.98 HTT (0.55) HTTCHRNB2CHRNA3CHRNA4CHRNB3
Hydrochloric Acid SCHEMBL17560454 0.98 HTT (0.55) HTTCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL30032495 0.94 EPHX1 (0.57) HTTCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL8521234 0.92 HTT (0.63) HTTCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL8521203 0.92 HTT (0.69) HTTCHRNB2CHRNA3CHRNA4CHRNB3
Hydrochloric Acid SCHEMBL30473879 0.92 EPHX1 (0.55) HTTCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL12820446 0.91 HTT (0.49) HTTCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL652054 0.90 HTT (0.72) HTTPOLBHSD17B10EPHX1KDM4E
Water SCHEMBL29943750 0.90 HTT (0.67) HTTPOLBHSD17B10EPHX1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092091-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS Humanwell Pharmaceutical US 2025-03-20 — — US disclosed
US-12215173-B2 Kappa opioid receptor peptide amide ligands HUMANWELL PHARMACEUTICAL US, Inc. (US) 2025-02-04 — — US disclosed
CN-118459452-B PolyADP ribose hydrolase inhibitor and application thereof 苏州国匡医药科技有限公司 2024-10-25 — — CN disclosed
CN-118459452-A PolyADP ribose hydrolase inhibitor and application thereof 苏州国匡医药科技有限公司 2024-08-09 — — CN disclosed
CN-114615976-A Kappa opioid receptor peptide amide agonists 人福医药美国公司 2022-06-10 — — CN disclosed
WO-2021026492-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS Humanwell Pharmaceutical US (US) 2021-02-11 — — WO disclosed
US-20210040150-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) 2021-02-11 — — US disclosed
WO-2021026492-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS Humanwell Pharmaceutical US (US) 2021-02-11 — — WO disclosed
US-20210040150-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) 2021-02-11 — — US disclosed
EP-2799435-B1 POLY (ADP-RIBOSE) POLYMERASE INHIBITOR CHENGDU DIAO PHARMACEUTICAL GROUP CO LTD (CN) 2018-03-28 — — EP disclosed
US-20050209279-A1 Process for production of piperidine derivatives AMR TECHNOLOGY, INC. (US) 2005-09-22 — — US disclosed
US-6919458-B2 Process for production of piperidine derivatives AMR TECHNOLOGY, INC. (US) 2005-07-19 — — US disclosed
EP-0868182-B1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RES INC (US) 2003-09-03 — — EP disclosed
US-20030028029-A1 Process for production of piperidine derivatives BARCLAYS BANK PLC, AS THE COLLATERAL AGENT 2003-02-06 — — US disclosed
US-6458958-B1 PROCESS OF PREPARING A PIPERIDINE DERIVATIVE COMPOUND OF THE FORMULA: ACYLATING AN .ALPHA.,.ALPHA.-DISUBSTITUTED-METHYLBENZENE DERIVATIVE HAVING THE FORMULA: ALBANY MOLECULAR RESEARCH, INC. 2002-10-01 — — US disclosed
US-6444824-B1 ANTISEROTONINE AGENTS; SIDE EFFECT REDUCTION ALBANY MOLECULAR RESEARCH, INC. 2002-09-03 — — US disclosed
US-6153754-A Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2000-11-28 — — US disclosed
EP-0868182-A4 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RES INC (US) 1999-04-07 — — EP disclosed
EP-0868182-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1998-10-07 — — EP disclosed
WO-1997023213-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1997-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250092091-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS OPRK1, OPRL1, OPRD1 HTT 2400/4885CHRNB2 221/4885CHRNA3 94/4885
US-20050209279-A1 Process for production of piperidine derivatives NR5A2, NR4A1, NR4A2 HTT 3976/4885CHRNB2 373/4885CHRNA3 156/4885
US-12215173-B2 Kappa opioid receptor peptide amide ligands OPRK1, OPRL1, OPRD1 HTT 2400/4885CHRNB2 221/4885CHRNA3 94/4885
US-20210040150-A1 KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS OPRK1, OPRL1, OPRD1 HTT 2268/4885CHRNB2 207/4885CHRNA3 83/4885
US-20030028029-A1 Process for production of piperidine derivatives NR4A1, RCOR1, CBR1 HTT 3427/4885CHRNB2 1094/4885CHRNA3 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.